BMC pulmonary medicineHumansMaleMiddle AgedAntibodiesMonoclonal
Unmasking EGPA with near fatal diffuse alveolar haemorrhage in severe eosinophilic asthma under treatment with benralizumab: a case report.
Nora Drick, Till Frederik Kaireit, Jannik Ruwisch, Sven Schallhorn, Johann Bauersachs, Heiko Schenk, Marius M Hoeper, Torsten Witte, Benjamin Seeliger
Published: 202610.1186/s12890-026-04106-4
Abstract
BACKGROUND: Eosinophils are key factors to the pathogenesis of severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA). Monoclonal antibodies targeting the interleukin-5 (IL-5) pathway (mepolizumab and benralizumab) often…
Preview only. Read the full abstract at the source